{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:54:09Z","timestamp":1775058849046,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p><jats:italic>Campylobacter jejuni<\/jats:italic> is a motile, gram-negative rod known for causing self-limiting enterocolitis while rarely causing extraintestinal infections. We report the first case of a patient with <jats:italic>Campylobacter jejuni<\/jats:italic> osteomyelitis in both femora.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 54-year-old female presented with progressive pain in both upper extremities. Her past medical history mentioned a lymphoplasmacytic lymphoma (LPL) for which she had received dexamethasone, cyclophosphamide and fludarabine and was still receiving maintenance therapy with intravenous rituximab. Two months prior to presentation, she received oral fluoroquinolone for a recurrent enterocolitis with stool cultures positive for <jats:italic>Campylobacter jejuni<\/jats:italic>. Palpation of the left quadriceps femoris muscle was remarkably painful during physical examination. Laboratory testing showed elevated C-reactive protein and recent low gamma globulin levels. The presumptive diagnosis at this point was a transformation of LPL to a large B cell lymphoma. In order to determine the preferred site for biopsy, a fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography was done. However, blood cultures taken on admission showed growth of <jats:italic>Campylobacter jejuni<\/jats:italic> in both aerobic bottles, with a strain resistant to fluoroquinolones. Diagnosis of <jats:italic>Campylobacter jejuni<\/jats:italic> osteomyelitis was confirmed with 16S ribosomal RNA gene polymerase chain reaction performed on femoral bone obtained through biopsy. Treatment with intravenous imipenem\/cilastatin followed by intravenous and oral doxycycline proved insufficient. Subsequently, the patient was treated successfully with intravenous meropenem for six weeks and concurrent intravenous immunoglobulin.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We report the first case of <jats:italic>Campylobacter jejuni<\/jats:italic> osteomyelitis in both femora in a patient with acquired hypogammaglobulinemia. Diagnosis was confirmed by blood cultures and positive 16S ribosomal RNA gene polymerase chain reaction for <jats:italic>Campylobacter<\/jats:italic> spp. on bone biopsy. Treatment was successful with intravenous meropenem and immunoglobulin. Our report showcases an unusual manifestation in a patient with immunodeficiency and discusses failure of initial antibiotic therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-4929-8","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T17:02:31Z","timestamp":1583514151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Two-sided femoral Campylobacter jejuni osteomyelitis in a patient with acquired hypogammaglobulinemia: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-3856","authenticated-orcid":false,"given":"Joost","family":"Hartman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Westerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri F. P.","family":"Wagenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"issue":"218","key":"4929_CR1","first-page":"2485","volume":"1","author":"BM Allos","year":"2015","unstructured":"Allos BM, Iovine NM, Blaser MJ. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases, Eighth Edition. Elsevier Saunders. 2015;1(218):2485\u201393.","journal-title":"Elsevier Saunders"},{"key":"4929_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MD.0b013e3181f2638d","volume":"89","author":"A Fern\u00e1ndez-Cruz","year":"2010","unstructured":"Fern\u00e1ndez-Cruz A, Mu\u00f1oz P, Mohedano R, Valerio M, Mar\u00edn M, Alcal\u00e1 L, et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore). 2010;89:319\u201330. https:\/\/doi.org\/10.1097\/MD.0b013e3181f2638d.","journal-title":"Medicine (Baltimore)"},{"key":"4929_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1473-3099(17)30466-8","volume":"17","author":"I Puljiz","year":"2017","unstructured":"Puljiz I, Topic A. Campylobacter jejuni vertebral osteomyelitis. Lancet Infect Dis. 2017;17:1002. https:\/\/doi.org\/10.1016\/S1473-3099(17)30466-8.","journal-title":"Lancet Infect Dis"},{"key":"4929_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0000000000007238","volume":"96","author":"Y Kim","year":"2017","unstructured":"Kim Y, Shin JA, Han SB, Cho B, Jeong DC, Kang JH. Recurrent campylobacter jejuni bacteremia in a patient with hypogammaglobulinemia. Medicine. 2017;96:25. https:\/\/doi.org\/10.1097\/MD.0000000000007238.","journal-title":"Medicine."},{"key":"4929_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","volume":"13","author":"C Casulo","year":"2013","unstructured":"Casulo C, Maragulia J, Zelenetz AD. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. Clin Lymphoma Myeloma Leuk. 2013;13:106\u201311. https:\/\/doi.org\/10.1016\/j.clml.2012.11.011.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4929_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/BF02098467","volume":"12","author":"JCC Borleffs","year":"1993","unstructured":"Borleffs JCC, Schellekens JF, Brouwer E, Rozenberg-Arska M. Use of an immunoglobulin M containing preparation for treatment of two Hypogammaglobulinemic patients with persistent campylobacter jejuni infection. Eur J Clin Microbiol Infect Dis. 1993;12:772\u20135.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4929_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2017.01.010","volume":"31","author":"SK Schmitt","year":"2017","unstructured":"Schmitt SK. Osteomyelitis. Infect Dis Clin N Am. 2017;31:325\u201338. https:\/\/doi.org\/10.1016\/j.idc.2017.01.010.","journal-title":"Infect Dis Clin N Am"},{"key":"4929_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0049-0172(05)80026-5","volume":"23","author":"CC Chang","year":"1993","unstructured":"Chang CC, Greenspan A, Gershwin ME. Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum. 1993;23:47\u201369.","journal-title":"Semin Arthritis Rheum"},{"key":"4929_CR9","first-page":"854","volume":"3","author":"ML Grayson","year":"2010","unstructured":"Grayson ML, Crowe SM, McCarthy KS, et al. Kucers\u2019 the Use of Antibiotics, Sixth Edition. Edward Arnold. 2010;3:854\u20135.","journal-title":"Edward Arnold"},{"key":"4929_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","volume":"81","author":"AK Thabit","year":"2019","unstructured":"Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF. Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis. 2019;81:128\u201336. https:\/\/doi.org\/10.1016\/j.ijid.2019.02.005.","journal-title":"Int J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4929-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:24:53Z","timestamp":1614990293000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4929-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4929-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"5 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained written consent from the patient for publication of their personal and clinical details and for publication of the image of F-18 FDG PET\/CT-scan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}